Who owns your GP clinic? Why insurer-backed primary care is raising questions about access and choice
A changing ownership picture in primary care
Australians generally expect their local GP clinic to be independent: a place where medical decisions are made at arm’s length from commercial pressures. But that assumption is being tested as major private health insurers expand their footprint beyond insurance policies and into the delivery of care itself.
Medibank Private and Bupa have been open about buying and opening GP clinics, quickly becoming significant healthcare providers in their own right. At the same time, the broader insurance market is shifting: all four major insurers now offer some free or heavily discounted GP telehealth-style consultations to members.
This expansion is not only about convenience. It signals a structural change in how care is organised and paid for. Doctors and policy observers are increasingly asking what it means for patients when the entity paying for health claims also owns, employs, or partners with the clinicians providing the care that can drive those claims.
Why telehealth is at the centre of the debate
Telehealth has become a key entry point for insurers into everyday healthcare. The model being promoted by insurers differs from Medicare-funded GP consultations in a crucial way: these insurer-provided telehealth consultations are not covered by Medicare, and the insurers are paying the full cost.
That arrangement is possible because of the interaction of two laws that, together, make this structure legal. The result is a product that can be offered at a price point that is difficult for traditional general practice to match, particularly in an environment where many GPs say Medicare rebates have not kept pace with the costs of running a practice.
Insurers argue that anyone can access these telehealth services. In a narrow sense, that is true. The concern raised by doctors is that the effective access is shaped by price. When members receive consultations for free or at a heavy discount, privately insured patients can find it easier and cheaper to obtain care through those channels.
In a system already facing GP shortages, this pricing dynamic matters. If insurer-led services are more attractive to patients because they are cheaper, and more attractive to clinicians because they may offer better remuneration or different working conditions, the market could tilt in ways that change who gets timely access to a GP.
Fears of a two-tier system
The phrase “two-tier system” is often used to describe a situation where one group receives faster or more affordable access to services than another, not because of clinical need but because of ability to pay or insurance status. Doctors are flagging that risk in relation to insurer-backed GP services and telehealth.
Australian Medical Association vice president Julian Rait has pointed to a specific pressure point: the shortage of GPs. In a tight workforce market, there is potential for insurer-led services to attract GPs to their organisations, particularly if they can offer better pay than traditional general practice that relies heavily on Medicare rebates.
That concern is amplified by long-standing critiques that Medicare rebates do not keep pace with costs. If the economics of standard practice become increasingly strained, it is easier to imagine a future in which some clinicians prefer models that are not Medicare-based—especially in the online telehealth space. The idea of “No Medicare” doctors, once unthinkable to many, has been raised as a realistic possibility in that context.
Lessons and warnings drawn from the United States
Debate about insurer involvement in care often invokes the United States, where “managed care” and insurance-driven networks are a well-known feature of the health system. In the US, it is not uncommon to see GP clinics with signs such as “No Medicaid patients” or “Insured patients only.” Those signs reflect a system where access can depend heavily on insurance coverage and reimbursement levels.
Medicaid in the US is a government-subsidised healthcare program for low-income earners. It is not the same as Australia’s Medicare, but it is often used in comparisons because it illustrates how reimbursement settings can shape provider behaviour. In the US, doctors can opt out of Medicaid, and sometimes do, because of low reimbursement rates. The outcome is that only some clinics accept Medicaid patients, leaving access uneven.
Australian insurers argue loudly that Australia’s system is vastly different from the US. There are genuine differences. Australia’s community rating system means anyone can buy health insurance, and it is not offered through employers in the same way. Insurers are also tightly regulated in what they can and can’t cover through the Basic-to-Gold policy system, and they must mostly mirror the Medicare committees that decide what is and is not covered.
Even with those differences, doctors say the comparison is still useful as a cautionary tale: once insurers have a stronger role in organising care, the incentives and boundaries can shift, particularly wherever laws allow influence over clinical pathways.
From paying claims to providing care: how far the expansion goes
The trend is not limited to GP clinics and telehealth. Medibank is also buying private hospitals and offering “hospital in the home” services through its subsidiary Amplar Health. This kind of vertical integration—where an insurer is involved in multiple stages of the patient journey—has prompted concern that Australia could be moving, gradually, toward an insurer-directed healthcare system commonly referred to as “managed care.”
Managed care is a broad term, but the underlying anxiety is consistent: if the organisation that profits from lower claims is also steering patients through a network of providers it owns or prefers, then the line between clinical judgement and financial incentives can become harder to see from the patient’s perspective.
Conflicts of interest and referral pathways
The Australian Medical Association has warned about the incentives created when a health insurer owns a GP clinic. The core concern is straightforward: ownership could encourage referrals to the insurer’s own hospitals or a preferred network of specialists.
There are rules intended to prevent inappropriate steering. However, the counterargument from doctors is that even with rules, the conflict of interest can be too great and the potential for perverse incentives too high. Referral patterns are not only a matter of explicit direction; they can be influenced by softer forces such as default options, internal pathways, or administrative processes that nudge clinicians toward certain providers.
In theory, a patient can take even a named referral anywhere. In practice, many patients rely on their doctor’s guidance about which specialist to see and which hospital best suits their condition. That reliance is not irrational; healthcare is complex, and patients often need help navigating it. But it does mean that subtle shifts in referral culture can have real effects on choice.
Insurers may frame their involvement as a way to save patients money. Doctors caution that the trade-off can be reduced choice. And when choice is reduced, a common outcome is higher prices over time, particularly in markets where a smaller number of providers control access.
Insurer influence beyond clinics: prostheses, rehab limits and claim handling
Some specialists say they are already seeing signs of insurer encroachment in private hospital care. Orthopaedic surgeons, who perform a large share of private hospital work, report concerns about policies not covering certain prostheses they would like to use. They also raise claims about rehabilitation limits in insurer contracts with hospitals—an issue the industry disputes.
Another example raised in the debate comes from an ombudsman’s review of type C certificates. These certificates can allow a procedure that is normally done in a specialist’s rooms to be performed in a hospital and claimed on private health insurance. One scenario described is a Parkinson’s patient who might need sedation in hospital to receive an eye injection.
The ombudsman found some health insurers were questioning these certificates and leaving them in limbo, effectively rejecting claims by inertia rather than an explicit decision. For clinicians and patients, delays and uncertainty in claim processing can be consequential, particularly when they affect access to time-sensitive care.
Preventive care pilots: promise and unanswered questions
Not every insurer initiative is framed as cost control. Some projects are presented as genuinely well-intentioned attempts to improve health outcomes, including preventive care pilots embedded in GP clinics.
One such pilot in preventive health was launched in 2024 at three Myhealth medical centres. It is accessible to anyone, including a program run by Medibank Private in western Sydney. There is no suggestion that there is anything wrong with the pilot itself.
Still, doctors point to a theoretical issue that arises whenever an insurer is closely involved in care delivery: the insurer stands to benefit if it reduces hospitalisations and therefore insurance claims for its members. That is not inherently improper—prevention that reduces hospital admissions is widely seen as positive. The concern is about how benefits are distributed and whether the structure could create preferential treatment for insured patients, or whether patients might be told where or when they can access certain interventions.
These are not abstract worries in a system with constrained capacity. If GP appointments are scarce, any model that changes the queue—by price, membership status, or internal pathways—can reshape access in ways that feel unequal even when services are technically “available” to all.
What government is saying
Health Minister Mark Butler has said the government does not support a two-tier system. That statement reflects a policy preference for maintaining broadly equitable access to care.
At the same time, doctors and critics argue that elements of a two-tier dynamic are already beginning to emerge, driven less by formal policy changes and more by market behaviour: insurer-funded telehealth at discounted prices for members, the purchase of clinics, and deeper partnerships across the health sector.
Why regulation may not settle the argument
Australia’s private health insurance sector is regulated, and insurers emphasise that they cannot simply replicate US-style arrangements. The community rating system, the Basic-to-Gold product tiers, and the requirement to mostly mirror Medicare committee decisions all act as constraints.
Yet the debate persists because the pressure points are not only about what insurers are allowed to cover. They are also about how insurers can influence care through ownership, partnerships, and service design. When laws permit insurers to enter new parts of the health system, they can “creep into more health spaces” and test the boundaries of influence.
For patients, the practical question is not whether a system is identical to the US, but whether the direction of travel increases the role of insurance status in determining affordability and ease of access.
Key questions patients and policymakers are grappling with
The shift toward insurer-provided GP services and telehealth raises a set of questions that do not have simple answers, particularly in a health system balancing public funding, private insurance, and workforce shortages.
Access and affordability: If privately insured members can access cheaper consultations, does that effectively create a faster lane for some patients?
Workforce distribution: In a GP shortage, will better-paid insurer-led roles draw clinicians away from traditional practices, making access harder elsewhere?
Choice and competition: If referrals and pathways increasingly flow through insurer-owned or preferred networks, will patient choice narrow over time?
Conflicts of interest: Can rules adequately neutralise the incentives that come with insurers owning clinics, hospitals, or home-care services?
Claims and coverage friction: How should disputes over prostheses, rehab limits, or claim processing be handled to avoid care being delayed by administrative inertia?
The bigger picture: convenience today, structure tomorrow
Many Australians may welcome more telehealth options and a stronger emphasis on preventive care. In a strained system, services that reduce barriers to seeing a GP can feel like a practical improvement, especially when they are low-cost for patients.
But doctors urging caution argue that it is important to keep the bigger picture in view. Ownership and funding structures can shape behaviour gradually. A discount here, a clinic acquisition there, a hospital-at-home service added through a subsidiary—each step can appear incremental. Over time, the cumulative effect could be a healthcare landscape where insurance membership plays a larger role in determining how easily a patient can get in the door.
The debate is ultimately about what Australians want primary care to be: a broadly uniform front door to the health system, or a set of parallel entry points that differ in price and availability. As insurers become more active providers, that question is moving from the margins of policy discussion into the everyday reality of how patients book an appointment—and what it costs them.